Semax/Selank Blend

Description

Semax/Selank Research Peptide Semax/Selank is a dual research peptide formulation created to support advanced investigation into cognitive processes, neurological regulation, and stress-associated signaling pathways. By combining two well-characterized synthetic heptapeptides, this formulation enables researchers to study complementary neurobiological mechanisms within a single compound system. Semax originates from a modified fragment of adrenocorticotropic hormone and is commonly examined for its involvement in neurotrophic activity. Research suggests that Semax plays a role in regulating the expression of brain-derived neurotrophic factor and nerve growth factor, both of which contribute to neuronal development, synaptic adaptability, and learning-related signaling. Additionally, Semax influences dopamine and serotonin activity, which has made it a frequent subject of interest in cognitive performance and focus-oriented research. Its extended Pro-Gly-Pro sequence enhances molecular stability by reducing susceptibility to enzymatic degradation. Selank is a stabilized synthetic analogue of the naturally occurring immunomodulatory peptide tuftsin. Researchers primarily investigate Selank for its effects on stress modulation and anxiety-related signaling. Rather than directly stimulating receptor activity, Selank adjusts GABAergic signaling by increasing receptor responsiveness to endogenous ligands. This indirect mechanism allows for exploration of regulatory pathways without inducing strong sedative effects. Selank also slows the breakdown of enkephalins, compounds involved in emotional balance and stress response regulation. When combined, Semax and Selank offer a balanced biochemical profile. Semax contributes stimulatory and neuroprotective characteristics, while Selank provides regulatory and calming influences. Both peptides exhibit strong structural stability and the ability to cross the blood-brain barrier, making Semax/Selank is suited for controlled laboratory and biochemical research applications. Key Research Features

Dual-peptide formulation combining Semax and Selank Synthetic heptapeptides engineered for enhanced molecular stability Studied for involvement in BDNF and neurotrophic signaling pathways Supports research across dopaminergic, serotonergic, and GABAergic systems Demonstrates resistance to rapid enzymatic degradation Intended for advanced neurological and biochemical research models

Semax/Selank allows researchers to evaluate complementary neuroregulatory pathways using a single, well-defined peptide combination within structured research settings.

Research Use Only – Legal Disclaimer

All Eagle Peptides products labeled as Research Use Only (RUO) are intended strictly for laboratory, investigational, and scientific research purposes. These materials are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind. By purchasing or using RUO materials, you acknowledge that they will be handled only within an appropriate research environment by qualified personnel who understand the risks, limitations, and regulatory requirements associated with experimental compounds. Products must not be administered to humans or animals, offered as therapeutic agents, or represented as safe or effective for any medical purpose. Use of these materials is entirely at your own risk. Eagle Peptides assumes no liability for misuse, unsafe handling, improper application, or any regulatory or compliance issues arising from their use.